Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3257-2026

Brand Name: VOLARA System Product Name: VOLARA, HC, NA A Recall

Brand Name: VOLARA System Product Name: VOLARA, HC, NA A Model/Catalog Number: M08594A Software Version: N/A Product Description: VOLARA, HOMECARE, NORTH AMERICA Component: No

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: VOLARA System Product Name: VOLARA, HC, NA A. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3257-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 3, 2026
FDA report date
Sep 30, 2026
Quantity in commerce
2
Distribution
See key details
FDA cause
Device Design

What is being recalled?

Brand Name: VOLARA System Product Name: VOLARA, HC, NA A Model/Catalog Number: M08594A Software Version: N/A Product Description: VOLARA, HOMECARE, NORTH AMERICA Component: No

Affected model & UDI checker

Search the exact identifiers published for Z-3257-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
M08594ABrand Name: VOLARA System Product Name: VOLARA, HC, NA ACheck source noticeNot specified
Not specifiedBrand Name: VOLARA System Product Name: VOLARA, HC, NA ACheck source notice00887761981690
FDA code information

Lot Code: UDI: 00887761981690 Serial Numbers: W078SY3553 and Z309SY7853

View the original FDA recall notice

Why was this product recalled?

Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to firm and testing confirmed devices meet specifications.

What actions did Baxter Healthcare Corporation take?

Affected consignees were notified by phone on August 3, 2026. Customers were informed that as a precaution, Baxter would replace impacted VOLARA devices. A Baxter clinical trainer would contact the customers to schedule a home visit to exchange the device. Customers were asked to continue to use the VOLARA device as prescribed until it was exchanged. As of August 13, 2026, all potentially affected devices have been returned to Baxter.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology